Year archive

Galapagos NV — 2013 filings

All 142 regulatory filings released by Galapagos NV (GLPG) in 2013, sourced directly from the official regulator.

142 Filings

2013 Period

2013 filings (142)

Filing	Released	Lang
Galapagos selects pre-clinical candidate for cystic fibrosis Regulatory Filings	2013-12-16	English
Galapagos selects pre-clinical candidate for cystic fibrosis Investor Presentation	2013-12-16	English
Galapagos selects pre-clinical candidate for cystic fibrosis Regulatory Filings	2013-12-16	English
Nieuw kandidaat medicijn tegen taaislijmziekte Regulatory Filings	2013-12-16	Dutch
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2013-12-08	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2013-12-08	English
Galapagos reports positive Phase 1 results for GLPG1205 Legal Proceedings Report	2013-12-04	English
Galapagos reports positive Phase 1 results for GLPG1205 Regulatory Filings	2013-12-04	English
Galapagos reports positive Phase 1 results for GLPG1205 Regulatory Filings	2013-12-04	English
Galapagos kondigt positieve Fase 1 resultaten aan met GLPG1205 Regulatory Filings	2013-12-04	Dutch
Galapagos announces GSK2586184 JAK1 molecule moves into Phase 2 for ulcerative colitis Earnings Release Q4 2013	2013-11-27	English
Galapagos announces GSK2586184 JAK1 molecule moves into Phase 2 for ulcerative colitis Regulatory Filings	2013-11-27	English
Galapagos announces GSK2586184 JAK1 molecule moves into Phase 2 for ulcerative colitis Regulatory Filings	2013-11-27	English
JAK1 molecuul GSK2586184 start klinische Fase 2 bij patiënten met chronische darmontsteking Regulatory Filings	2013-11-27	Dutch
Galapagos announces that BioFocus has signed an integrated drug discovery collaboration with Boehringer Ingelheim Regulatory Filings	2013-11-20	English
Galapagos announces that BioFocus has signed an integrated drug discovery collaboration with Boehringer Ingelheim Regulatory Filings	2013-11-20	English
Galapagos announces that BioFocus has signed an integrated drug discovery collaboration with Boehringer Ingelheim Regulatory Filings	2013-11-20	English
Galapagos kondigt drug discovery samenwerking aan met Boehringer Ingelheim Regulatory Filings	2013-11-20	Dutch
Galapagos business update Earnings Release Q3 2013	2013-11-15	English
Galapagos business update Earnings Release Q3 2013	2013-11-15	English
Q3 update 2013_FINAL.pdf Earnings Release Q3 2013	2013-11-15	English
Q3 update 2013_NL_FINAL.pdf Earnings Release Q3 2013	2013-11-15	Dutch
Galapagos subsidiary BioFocus signs agreement with Biogen Idec in scleroderma Regulatory Filings	2013-11-12	English
Galapagos subsidiary BioFocus signs agreement with Biogen Idec in scleroderma Regulatory Filings	2013-11-12	English
Galapagos subsidiary BioFocus signs agreement with Biogen Idec in scleroderma Regulatory Filings	2013-11-12	English
Galapagos’ service divisie en Biogen Idec tekenen overeenkomst in sclerodermie Regulatory Filings	2013-11-12	Dutch
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2013-10-22	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2013-10-22	English
Galapagos presents superior potentiator series for CF Earnings Release FY 2013	2013-10-17	English
Galapagos presents superior potentiator series for CF Investor Presentation	2013-10-17	English
Galapagos to present Phase 1 data on FFA2 antagonist GLPG0974 at UEG Week in Berlin Regulatory Filings	2013-10-16	English
Galapagos to present Phase 1 data on FFA2 antagonist GLPG0974 at UEG Week in Berlin Regulatory Filings	2013-10-16	English
Galapagos to present GLPG0634 at ACR Regulatory Filings	2013-10-16	English
Galapagos to present GLPG0634 at ACR Regulatory Filings	2013-10-16	English
Delta Lloyd notify of 9.93% shareholding in Galapagos Major Shareholding Notification	2013-10-01	English
Delta Lloyd notify of 9.93% shareholding in Galapagos Major Shareholding Notification	2013-10-01	English
trans notice_FINAL.pdf Major Shareholding Notification	2013-09-30	English
trans notice_NL.pdf Major Shareholding Notification	2013-09-30	Dutch
AbbVie and Galapagos to co-develop cystic fibrosis therapies Regulatory Filings	2013-09-24	English
AbbVie and Galapagos to co-develop cystic fibrosis therapies M&A Activity	2013-09-24	English
Galapagos creates new warrant plan Share Issue/Capital Change	2013-09-19	English
Galapagos creates new warrant plan Share Issue/Capital Change	2013-09-19	English
Galapagos appoints David Smith as CEO of Service Division Board/Management Information	2013-08-20	English
Galapagos appoints David Smith as CEO of Service Division Board/Management Information	2013-08-20	English
Galapagos half year revenues up 21% Interim / Quarterly Report H1 2013	2013-08-09	English
Half Year Results 2013.pdf Interim / Quarterly Report H1 2013	2013-08-09	English
Halfjaarverslag 2013.pdf Interim / Quarterly Report H1 2013	2013-08-09	Dutch
Galapagos delivers novel osteoarthritis molecules in alliance with Servier M&A Activity	2013-07-23	English
Galapagos delivers novel osteoarthritis molecules in alliance with Servier Regulatory Filings	2013-07-23	English
Galapagos receives €2.4 million IWT grant for psoriasis research Regulatory Filings	2013-07-08	English
Galapagos receives €2.4 million IWT grant for psoriasis research Regulatory Filings	2013-07-08	English
Galapagos initiates Phase 1 trial as part of its alliance with Janssen Pharmaceutica NV Regulatory Filings	2013-07-02	English
Galapagos initiates Phase 1 trial as part of its alliance with Janssen Pharmaceutica NV Regulatory Filings	2013-07-02	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2013-07-02	English
Galapagos increases share capital through warrant exercises Share Issue/Capital Change	2013-07-02	English
First patients screened for Phase 2B studies with GLPG0634 Regulatory Filings	2013-07-01	English
First patients screened for Phase 2B studies with GLPG0634 Earnings Release Q3 2013	2013-07-01	English
Galapagos presents GLPG0634 at EULAR poster session Investor Presentation	2013-06-13	English
Galapagos presents GLPG0634 at EULAR poster session Regulatory Filings	2013-06-13	English
Galapagos creates new warrant plan Share Issue/Capital Change	2013-05-20	English
Galapagos creates new warrant plan Share Issue/Capital Change	2013-05-20	English
1Q2013update_FINAL.pdf Regulatory Filings	2013-05-17	English
1Q2013update_NL_FINAL.pdf Regulatory Filings	2013-05-17	Dutch
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease Regulatory Filings	2013-05-17	English
AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease Regulatory Filings	2013-05-17	English
Galapagos business update Earnings Release Q1 2013	2013-05-17	English
Galapagos business update Earnings Release Q1 2013	2013-05-17	English
Galapagos to present three posters on GLPG0634 at EULAR Regulatory Filings	2013-05-14	English
Galapagos to present three posters on GLPG0634 at EULAR Regulatory Filings	2013-05-14	English
Galapagos rondt private plaatsing af door uitgifte van 2.696.831 nieuwe aandelen Share Issue/Capital Change	2013-04-30	Dutch
Galapagos rondt private plaatsing af door uitgifte van 2.696.831 nieuwe aandelen Share Issue/Capital Change	2013-04-30	Dutch
NYSE LIFFE introduceert aandelenopties GALAPAGOS Regulatory Filings	2013-04-30	Dutch
NYSE LIFFE introduceert aandelenopties GALAPAGOS Regulatory Filings	2013-04-30	Dutch
Galapagos haalt €54 miljoen op Share Issue/Capital Change	2013-04-25	Dutch
Galapagos haalt €54 miljoen op Share Issue/Capital Change	2013-04-25	Dutch
Galapagos start Fase 2A studie met GLPG0974 bij patiënten met colitis ulcerosa Legal Proceedings Report	2013-04-23	Dutch
Galapagos start Fase 2A studie met GLPG0974 bij patiënten met colitis ulcerosa Regulatory Filings	2013-04-23	Dutch
Galapagos ontdekt nieuw kandidaat-medicijn voor behandeling borstkanker Regulatory Filings	2013-04-22	Dutch
Galapagos ontdekt nieuw kandidaat-medicijn voor behandeling borstkanker Regulatory Filings	2013-04-22	Dutch
Galapagos presenteert opzet Fase 2b studie GLPG0634 Regulatory Filings	2013-04-17	Dutch
Galapagos presenteert opzet Fase 2b studie GLPG0634 Regulatory Filings	2013-04-17	Dutch
Galapagos presents scope of GLPG0634 Phase 2b program Regulatory Filings	2013-04-16	English
Galapagos presenteert opzet Fase 2b studie GLPG0634 Share Issue/Capital Change	2013-04-16	Dutch
Gestion Deelnemingen V geven kennis van deelneming van 4,97% in Galapagos Major Shareholding Notification	2013-04-15	Dutch
Gestion Deelnemingen V geven kennis van deelneming van 4,97% in Galapagos Major Shareholding Notification	2013-04-15	Dutch
trans notice_FINAL.pdf Major Shareholding Notification	2013-04-12	English
trans notice_NL_FINAL.pdf Major Shareholding Notification	2013-04-12	Dutch
Galapagos verhoogt kapitaal door uitoefening van warrants Share Issue/Capital Change	2013-04-09	Dutch
Galapagos verhoogt kapitaal door uitoefening van warrants Share Issue/Capital Change	2013-04-09	Dutch
Share capital increase_FINAL.pdf Share Issue/Capital Change	2013-04-08	English
Share capital increase_NL_FINAL.pdf Share Issue/Capital Change	2013-04-08	Dutch
Proxy_Form.pdf Proxy Solicitation & Information Statement	2013-03-30	English
Volmachtformulier.pdf Proxy Solicitation & Information Statement	2013-03-30	Dutch
Galapagos_NV_-_Jaarrekening_2012_voor_AV_30-04-2013.pdf Annual Report FY 2012	2013-03-30	English
Galapagos_NV_-_Jaarrekening_2012.pdf Annual Report FY 2012	2013-03-30	Dutch
Galapagos_Annual_Report_2012.pdf Annual Report FY 2012	2013-03-30	English
Formulier voor kennisgeving van deelname.pdf AGM Information	2013-03-30	Dutch
Formulier_voor_kennisgeving_van_deelname.pdf AGM Information	2013-03-30	English
Aantal aandelen en stemrechten.pdf Share Issue/Capital Change	2013-03-30	Dutch
Auditors_Report_on_the_non-consolidated_financial_statements_per_31_December_2012.pdf Audit Report / Information FY 2012	2013-03-30	English
Galapagos_Jaarverslag_2012.pdf Annual Report FY 2012	2013-03-30	Dutch
Aantal_aandelen_en_stemrechten.pdf Share Issue/Capital Change	2013-03-30	English
Commissarisverslag_m.b.t._de_enkelvoudige_jaarrekening_per_31_december_2....pdf Audit Report / Information FY 2012	2013-03-30	Dutch
130326_AGM_130430_What_to_do_E.pdf AGM Information	2013-03-30	English
130326_AGM_130430_What_to_do_D.pdf AGM Information	2013-03-30	Dutch
Convening_notice_for_the__AGM_of_30_April_2013.pdf AGM Information	2013-03-30	English
Oproeping_tot_de_AV_van_30_April_2013.pdf AGM Information	2013-03-30	Dutch
Galapagos_Annual_Report_2012.pdf Annual Report FY 2012	2013-03-30	English
Galapagos_Jaarverslag_2012.pdf Annual Report FY 2012	2013-03-30	Dutch
Galapagos geeft R&D Update Investor Presentation	2013-03-27	Dutch
Galapagos geeft R&D Update Regulatory Filings	2013-03-27	Dutch
Galapagos start Fase 2a studie met GLPG0974 bij patiënten met chronische darmontsteking Earnings Release Q1 2013	2013-03-27	Dutch
Galapagos start Fase 2a studie met GLPG0974 bij patiënten met chronische darmontsteking Regulatory Filings	2013-03-27	Dutch
Galapagos geeft jaarlijkse R&D update op 27 maart Report Publication Announcement	2013-03-21	Dutch
Galapagos geeft jaarlijkse R&D update op 27 maart Investor Presentation	2013-03-21	Dutch
Galapagos en Roche komen overeen alliantie te beëindigen Legal Proceedings Report	2013-03-08	Dutch
Galapagos en Roche komen overeen alliantie te beëindigen M&A Activity	2013-03-08	Dutch
Galapagos boekt recordomzet in 2012, klinische pijplijn is veelbelovend Earnings Release FY 2012	2013-03-08	Dutch
Galapagos boekt recordomzet in 2012, klinische pijplijn is veelbelovend Earnings Release FY 2012	2013-03-08	Dutch
FY2012 FINANCIAL TABLES.pdf Annual Report FY 2012	2013-03-08	English
Galapagos_Jaarverslag_2012.pdf Annual Report FY 2012	2013-03-08	Dutch
Galapagos_Annual_Report_2012.pdf Annual Report FY 2012	2013-03-08	English
FY2012 FINANCIAL TABLES NL.pdf Audit Report / Information FY 2012	2013-03-08	Dutch
FY2012_FINAL.pdf Earnings Release FY 2012	2013-03-08	English
FY2012_FINAL_NL.pdf Earnings Release FY 2012	2013-03-08	Dutch
Galapagos ontvangt €7,5 miljoen in Servier allianties Earnings Release FY 2012	2013-03-06	Dutch
Galapagos ontvangt €7,5 miljoen in Servier allianties M&A Activity	2013-03-06	Dutch
Galapagos announces GSK2586184 JAK1 molecule progresses to Phase 2 studies Legal Proceedings Report	2013-02-05	English
Galapagos announces GSK2586184 JAK1 molecule progresses to Phase 2 studies Regulatory Filings	2013-02-05	English
Galapagos krijgt €2,5 miljoen subsidie voor IBD onderzoek Regulatory Filings	2013-01-30	Dutch
Galapagos levert kandidaat-medicijn in alliantie met Janssen Pharmaceutica NV en ontvangt €4 miljoen succesbetaling Regulatory Filings	2013-01-16	Dutch
Galapagos levert kandidaat-medicijn in alliantie met Janssen Pharmaceutica NV en ontvangt €4 miljoen succesbetaling Regulatory Filings	2013-01-16	Dutch
Galapagos neemt Cangenix over, nieuwe expertise in medicijn ontwikkeling M&A Activity	2013-01-15	Dutch
Galapagos neemt Cangenix over, nieuwe expertise in medicijn ontwikkeling M&A Activity	2013-01-15	Dutch
Galapagos richt Fidelta op, een derde Galapagos service divisie Regulatory Filings	2013-01-15	Dutch
Galapagos richt Fidelta op, een derde Galapagos service divisie Regulatory Filings	2013-01-15	Dutch
Galapagos krijgt €2,7 miljoen IWT subsidie voor antibiotica onderzoek Regulatory Filings	2013-01-10	Dutch
Galapagos krijgt €2,7 miljoen IWT subsidie voor antibiotica onderzoek Regulatory Filings	2013-01-10	Dutch
Galapagos levert kandidaat-medicijn in alliantie met GSK en ontvangt succesbetaling Regulatory Filings	2013-01-09	Dutch
Galapagos levert kandidaat-medicijn in alliantie met GSK en ontvangt succesbetaling Regulatory Filings	2013-01-09	Dutch
Galapagos presenteert op de 31ste jaarlijkse J. P. Morgan Healthcare Conferentie Report Publication Announcement	2013-01-07	Dutch
Galapagos presenteert op de 31ste jaarlijkse J. P. Morgan Healthcare Conferentie Investor Presentation	2013-01-07	Dutch

Filings by year

2026 99 filings
2025 162 filings
2024 118 filings
2023 121 filings
2022 167 filings
2021 183 filings
2020 156 filings
2019 324 filings
2018 205 filings
2017 196 filings
2016 217 filings
2015 187 filings
2014 183 filings
2013 142 filings
2012 105 filings
2011 124 filings
2010 42 filings
2009 39 filings
2008 31 filings
2007 27 filings
2006 15 filings
2005 12 filings